GMED Globus Medical, Inc.
Platform & Compounding FCF
B- 65.0 / 100 composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

Profitability

Weight: 25%
F 27
  • 5yr Avg ROIC 5.5%
  • Operating Margin Trend -1.89 pp/yr

Capital Efficiency

Weight: 15%
F 22
  • 5yr Avg ROE 4.8%
  • 5yr Share-Count CAGR 7.3%

Growth Quality

Weight: 25%
A+ 100
  • 5yr Revenue CAGR 32.3%
  • 5yr EPS CAGR 28.4%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 20%
A- 85
  • 5yr FCF Margin 16.0%
  • 5yr FCF/NI Conversion 1.68x

Balance Sheet

Weight: 10%
A+ 99
  • Net Debt / EBITDA -0.60x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 11.41

Stability

Weight: 5%
B- 62
  • EPS Volatility (σ/μ) 0.58
  • Piotroski F-Score 8
  • Negative-Revenue Years (5) 0/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

3 of 3 gurus held; 2 added; 1 trimmed.

Holders
3
Avg Δ position
+2.0%
New buys
0
Full exits
0
As of Q1 2026